IL166021A0 - Trabsolant acceptance inducing cells of monocytic origin and their preparation and use - Google Patents

Trabsolant acceptance inducing cells of monocytic origin and their preparation and use

Info

Publication number: IL166021A0
Authority: IL; Israel
Prior art keywords: inducing cells; trabsolant; preparation; acceptance; monocytic origin
Prior art date: 2002-07-12

Application number

IL16602103A

Other languages

English (en)

Original Assignee

Blasticon Biotech Forschung

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-12

Filing date

2003-07-11

Publication date

2006-01-15

2003-07-11 Application filed by Blasticon Biotech Forschung filed Critical Blasticon Biotech Forschung

2006-01-15 Publication of IL166021A0 publication Critical patent/IL166021A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/17—Monocytes; Macrophages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/22—Immunosuppressive or immunotolerising
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/24—Antigen-presenting cells [APC]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/418—Antigens related to induction of tolerance to non-self
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/24—Interferons [IFN]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Genetics & Genomics (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Zoology (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
General Engineering & Computer Science (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmacology & Pharmacy (AREA)
Hematology (AREA)
Cell Biology (AREA)
Transplantation (AREA)
Gastroenterology & Hepatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Mycology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

IL16602103A 2002-07-12 2003-07-11 Trabsolant acceptance inducing cells of monocytic origin and their preparation and use IL166021A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10231655A DE10231655A1 (de)	2002-07-12	2002-07-12	Transplantat-Akzeptanz induzierende Zellen monozytären Ursprungs, sowie deren Herstellung und Verwendung
PCT/EP2003/007551 WO2004007701A1 (en)	2002-07-12	2003-07-11	Transplant acceptance inducing cells of monocytic origin and their preparation and use

Publications (1)

Publication Number	Publication Date
IL166021A0 true IL166021A0 (en)	2006-01-15

Family

ID=30009939

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
IL16602103A IL166021A0 (en)	2002-07-12	2003-07-11	Trabsolant acceptance inducing cells of monocytic origin and their preparation and use
IL166021A IL166021A (en)	2002-07-12	2004-12-28	Transplant acceptance inducing cells of monocytic origin and their preparation and use
IL172854A IL172854A0 (en)	2002-07-12	2005-12-27	Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical preparations

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
IL166021A IL166021A (en)	2002-07-12	2004-12-28	Transplant acceptance inducing cells of monocytic origin and their preparation and use
IL172854A IL172854A0 (en)	2002-07-12	2005-12-27	Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical preparations

Country Status (18)

Country	Link
US (1)	US20060286670A1 (de)
EP (2)	EP1557462B1 (de)
JP (1)	JP2005532803A (de)
CN (1)	CN100523176C (de)
AT (2)	ATE390480T1 (de)
AU (1)	AU2003250939B2 (de)
BR (1)	BR0312693A (de)
CA (1)	CA2492383A1 (de)
DE (3)	DE10231655A1 (de)
DK (2)	DK1557462T3 (de)
ES (3)	ES2304647T3 (de)
IL (3)	IL166021A0 (de)
NO (1)	NO20050719L (de)
PT (2)	PT1557462E (de)
RU (1)	RU2370535C2 (de)
SI (3)	SI1492869T1 (de)
WO (1)	WO2004007701A1 (de)
ZA (2)	ZA200501054B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10362002B4 (de)	2003-06-23	2006-10-12	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Adulte pluripotente Stammzellen
AU2004256154A1 (en) *	2003-07-11	2005-01-20	Blasticon Biotechnologische Forschung Gmbh	Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical proparations
EP1928479B1 (de) *	2005-08-24	2016-06-08	Yeda Research And Development Co., Ltd.	Universale von spendern stammende tolerogene zellen zur induktion von nicht-syngener transplantationstoleranz
US8470316B2 (en)	2005-10-14	2013-06-25	Chugai Seiyaku Kabushiki Kaisha	Agents for suppressing damage to transplanted islets after islet transplantation
CA2626688C (en)	2005-10-21	2017-10-03	Chugai Seiyaku Kabushiki Kaisha	Agents for treating cardiopathy
AR057582A1 (es)	2005-11-15	2007-12-05	Nat Hospital Organization	Agentes para suprimir la induccion de linfocitos t citotoxicos
US9260516B2 (en)	2006-04-07	2016-02-16	Osaka University	Method for promoting muscle regeneration by administering an antibody to the IL-6 receptor
WO2008090901A1 (ja) *	2007-01-23	2008-07-31	Shinshu University	慢性拒絶反応抑制剤
CN104906581A (zh)	2008-06-05	2015-09-16	国立研究开发法人国立癌症研究中心	神经浸润抑制剂
EP2365823B1 (de) *	2008-10-30	2016-11-30	Yeda Research And Development Company Ltd.	Zentrale anti-dritte-t-gedächtniszellen, verfahren zur herstellung davon und verwendung davon in der transplantation und bei der krankheitsbehandlung
JP5436905B2 (ja) *	2009-03-26	2014-03-05	テルモ株式会社	シート状細胞培養物の製造方法
JP5667357B2 (ja) *	2009-11-30	2015-02-12	テルモ株式会社	シート状細胞培養物の製造方法
CN101812428A (zh) *	2010-04-26	2010-08-25	西北农林科技大学	一种乳腺上皮细胞的组织块种植方法
US9539322B2 (en)	2010-05-28	2017-01-10	National University Corporation Hokkaido University	Method of enhancing an antitumor T cell response by administering an anti-IL-6 receptor antibody
DE102011004335A1 (de)	2011-02-17	2012-08-23	Thomas Grammel	Verfahren zur Herstellung eines Vakzins
RU2508924C1 (ru) *	2013-02-21	2014-03-10	Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского"	Способ профилактики и лечения отторжения почечного трансплантата
JP5727665B2 (ja) *	2014-12-11	2015-06-03	テルモ株式会社	シート状細胞培養物の製造方法
JP5893786B2 (ja) *	2015-04-02	2016-03-23	テルモ株式会社	シート状細胞培養物の製造方法
CA2991077A1 (en) *	2015-07-03	2017-01-12	Inserm (Institut National De La Sante Et De La Recherche Medicale)	Methods for obtaining regulatory t cells and uses thereof
JP6903866B2 (ja) *	2016-01-27	2021-07-14	国立大学法人熊本大学	血液由来単球の増殖誘導方法
JP6140322B2 (ja) *	2016-02-24	2017-05-31	テルモ株式会社	シート状細胞培養物の製造方法
JP6490738B2 (ja) *	2017-04-28	2019-03-27	テルモ株式会社	シート状細胞培養物の製造方法
US11851486B2 (en)	2017-05-02	2023-12-26	National Center Of Neurology And Psychiatry	Method for predicting and evaluating therapeutic effect in diseases related to IL-6 and neutrophils
EP3698808B1 (de)	2017-10-20	2025-01-01	Hyogo College Of Medicine	Anti-il-6 rezeptorantikörper enthaltende medizinische zusammensetzung zur verhinderung von postoperativer adhäsion
JP6657452B2 (ja) *	2019-02-27	2020-03-04	テルモ株式会社	シート状細胞培養物の製造方法
JP7002497B2 (ja) *	2019-06-20	2022-01-20	テルモ株式会社	シート状細胞培養物の製造方法
JP6872051B2 (ja) *	2020-02-05	2021-05-19	テルモ株式会社	シート状細胞培養物の製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5766920A (en) *	1982-08-11	1998-06-16	Cellcor, Inc.	Ex vivo activation of immune cells
US5683693A (en) *	1994-04-25	1997-11-04	Trustees Of Dartmouth College	Method for inducing T cell unresponsiveness to a tissue or organ graft with anti-CD40 ligand antibody or soluble CD40
US7410773B2 (en) *	1995-02-02	2008-08-12	Ghazi Jaswinder Dhoot	Method of preparing an undifferentiated cell
US9068164B1 (en) *	1995-02-02	2015-06-30	Tristem Trading (Cyprus) Limited	Method of preparing an undifferentiated cell
GB9502022D0 (en) *	1995-02-02	1995-03-22	Abuljadayel Ilham M S	A method for preparing lymphohaematopoietic progenitor cells
US7112440B2 (en) *	1995-02-02	2006-09-26	Ghazi Jaswinder Dhoot	Method of increasing the relative number of CD45 low cells in a cell population
ATE240119T1 (de) *	1995-03-08	2003-05-15	Scripps Research Inst	Antigen präsentierendes system und aktivierung von t-zellen
AU7499498A (en) *	1997-05-21	1998-12-11	Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The	Methods and compositions for making dendritic cells from expanded populations ofmonocytes and for activating t cells
NL1017973C2 (nl) *	2000-05-10	2002-11-08	Tristem Trading Cyprus Ltd	Inrichting.
US7405076B2 (en) *	2000-11-14	2008-07-29	Universite Libre De Bruxelles	Generation and use of dendritic cells
TWI288779B (en) *	2002-03-28	2007-10-21	Blasticon Biotech Forschung	Dedifferentiated, programmable stem cells of monocytic origin, and their production and use

2002
- 2002-07-12 DE DE10231655A patent/DE10231655A1/de not_active Ceased
2003
- 2003-07-11 AT AT05009317T patent/ATE390480T1/de not_active IP Right Cessation
- 2003-07-11 EP EP05009317A patent/EP1557462B1/de not_active Expired - Lifetime
- 2003-07-11 DE DE60302231T patent/DE60302231T2/de not_active Expired - Fee Related
- 2003-07-11 AT AT03763823T patent/ATE309331T1/de not_active IP Right Cessation
- 2003-07-11 AU AU2003250939A patent/AU2003250939B2/en not_active Ceased
- 2003-07-11 ES ES05009317T patent/ES2304647T3/es not_active Expired - Lifetime
- 2003-07-11 BR BR0312693-5A patent/BR0312693A/pt not_active IP Right Cessation
- 2003-07-11 PT PT05009317T patent/PT1557462E/pt unknown
- 2003-07-11 DK DK05009317T patent/DK1557462T3/da active
- 2003-07-11 SI SI200330146T patent/SI1492869T1/sl unknown
- 2003-07-11 WO PCT/EP2003/007551 patent/WO2004007701A1/en not_active Ceased
- 2003-07-11 IL IL16602103A patent/IL166021A0/xx unknown
- 2003-07-11 RU RU2005103627/13A patent/RU2370535C2/ru not_active IP Right Cessation
- 2003-07-11 CN CNB038215748A patent/CN100523176C/zh not_active Expired - Fee Related
- 2003-07-11 DK DK03763823T patent/DK1492869T3/da active
- 2003-07-11 DE DE60320009T patent/DE60320009T2/de not_active Expired - Fee Related
- 2003-07-11 SI SI200331240T patent/SI1557462T1/sl unknown
- 2003-07-11 EP EP03763823A patent/EP1492869B9/de not_active Expired - Lifetime
- 2003-07-11 ES ES03763823T patent/ES2252696T3/es not_active Expired - Lifetime
- 2003-07-11 CA CA002492383A patent/CA2492383A1/en not_active Abandoned
- 2003-07-11 JP JP2004520603A patent/JP2005532803A/ja active Pending
- 2003-07-11 US US10/520,931 patent/US20060286670A1/en not_active Abandoned
2004
- 2004-01-09 ES ES04701001T patent/ES2310711T3/es not_active Expired - Lifetime
- 2004-01-09 SI SI200430965T patent/SI1644484T1/sl unknown
- 2004-01-09 PT PT04701001T patent/PT1644484E/pt unknown
- 2004-12-28 IL IL166021A patent/IL166021A/en not_active IP Right Cessation
2005
- 2005-02-04 ZA ZA200501054A patent/ZA200501054B/xx unknown
- 2005-02-10 NO NO20050719A patent/NO20050719L/no not_active Application Discontinuation
- 2005-12-27 IL IL172854A patent/IL172854A0/en unknown
2006
- 2006-02-07 ZA ZA200601074A patent/ZA200601074B/en unknown

Also Published As

Publication number	Publication date
SI1557462T1 (sl)	2008-08-31
EP1492869A1 (de)	2005-01-05
AU2003250939B2 (en)	2008-05-22
CN100523176C (zh)	2009-08-05
JP2005532803A (ja)	2005-11-04
WO2004007701A1 (en)	2004-01-22
EP1492869B1 (de)	2005-11-09
ES2304647T3 (es)	2008-10-16
PT1557462E (pt)	2008-06-18
DK1492869T3 (da)	2006-03-06
DK1557462T3 (da)	2008-06-23
ATE309331T1 (de)	2005-11-15
PT1644484E (pt)	2008-10-21
CN1681918A (zh)	2005-10-12
BR0312693A (pt)	2005-04-26
DE60320009D1 (de)	2008-05-08
DE60320009T2 (de)	2009-05-20
DE60302231T2 (de)	2006-07-20
US20060286670A1 (en)	2006-12-21
SI1644484T1 (sl)	2009-02-28
EP1557462A3 (de)	2006-02-01
SI1492869T1 (sl)	2006-04-30
DE10231655A1 (de)	2004-02-26
NO20050719L (no)	2005-04-04
ES2252696T3 (es)	2006-05-16
IL166021A (en)	2010-05-17
EP1557462A2 (de)	2005-07-27
ATE390480T1 (de)	2008-04-15
ZA200501054B (en)	2005-08-30
CA2492383A1 (en)	2004-01-22
ZA200601074B (en)	2007-11-28
EP1492869B9 (de)	2006-05-24
ES2310711T3 (es)	2009-01-16
AU2003250939A1 (en)	2004-02-02
EP1557462B1 (de)	2008-03-26
DE60302231D1 (de)	2005-12-15
RU2370535C2 (ru)	2009-10-20
RU2005103627A (ru)	2005-08-27
HK1071586A1 (en)	2005-07-22
IL172854A0 (en)	2006-06-11

Publication	Publication Date	Title
IL166021A0 (en)	2006-01-15	Trabsolant acceptance inducing cells of monocytic origin and their preparation and use
IL195338A0 (en)	2011-08-01	Optimized fc variants and methods for their generation
UA92505C2 (ru)	2010-11-10	Композиции на основе антитела против cd3
MA30153B1 (fr)	2009-01-02	Anticorps anti-ox40l et methodes correspondantes
EA200300464A1 (ru)	2003-10-30	ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
TW200626171A (en)	2006-08-01	Fixed dosing of HER antibodies
MX337423B (es)	2016-03-04	Antagonistas anti-beta7 humanizados y usos para los mismos.
PL1699822T3 (pl)	2008-08-29	Białka fuzyjne IL-7 z częściami przeciwciała, ich otrzymywanie oraz ich zastosowanie
NZ588674A (en)	2013-02-22	Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
MX2009008918A (es)	2009-09-14	Activacion de celulas que presentan antigeno humano a traves de clec-6.
MXPA03004793A (es)	2004-12-03	Roedores transgenicos transcromosomales para elaborar anticuerpos humnanos.
TW200728466A (en)	2007-08-01	Antibody molecules having specificity for human IL-6
IL163902A0 (en)	2005-12-18	Antibodies against cancer antigen tmeff2 and uses thereof
UA94211C2 (ru)	2011-04-26	Выделенное полностью человеческое моноклональное cd3 антитело
EP1513397A4 (de)	2007-10-24	Transgene huftiere, die zur produktion von menschlichen antikörpern fähig sind
YU68602A (sh)	2006-03-03	Monoklonska antitela na humani ldl receptor, njihova produkcija i korišćenje
BR0313135A (pt)	2005-07-05	Epìtopos de células t em eritropoietina
EA200800601A1 (ru)	2009-08-28	Связывающие fas антитела
AU2003259750A8 (en)	2004-03-03	Methods and compositions for targeting secretory lysosomes
WO2005047456A3 (en)	2006-03-23	Anti-idiotype antibodies of the human monoclonal antibody sc-1, and their production and use
TW200519206A (en)	2005-06-16	Methods for producing novel medaka and novel medaka
MY142798A (en)	2010-12-31	Methods for preventing glyconoylation of proteins
NO20053829D0 (no)	2005-08-15	Fremgangsmate og intermediater for fremstilling av olanzapin.
LT2001122A (en)	2003-07-25	Method of propagation by layering